Zenicure Labs

Amlosky‑AT (Amlodipine 5mg + Atenolol 50mg Tablet) is a fixed‑dose combination antihypertensive that brings together a calcium channel blocker (CCB) and a beta‑blocker for comprehensive blood pressure and cardiac control.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Dual mechanism: Amlodipine relaxes blood vessels, Atenolol reduces heart rate and cardiac output.

• Angina Pectoris (Chest Pain)

  • Prevents episodes of angina by improving oxygen supply and reducing cardiac workload.

• Arrhythmias (Irregular Heartbeat)

  • Atenolol helps stabilize heart rhythm.

• Post‑Myocardial Infarction (Heart Attack)

  • Reduces risk of recurrent cardiac events by lowering strain on the heart.

• Combination Therapy Advantage

  • Provides better control in patients not responding adequately to monotherapy.

Atormae 10-Tablet belongs to a group of medicines called statins. It is used to lower cholesterol and to reduce the risk of heart diseases. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, which may lead to a heart attack or stroke.

Atormae‑A75 (Atorvastatin 10mg + Aspirin 75mg Capsules) is a cardiovascular protection combination that brings together a statin (lipid‑lowering agent) and an antiplatelet drug. It is widely prescribed for secondary prevention of heart disease and stroke.

📌 Key Medical Uses

• Coronary Artery Disease (CAD)

  • Prevents progression of atherosclerosis by lowering cholesterol and reducing clot formation.

• Post‑Myocardial Infarction (Heart Attack)

  • Reduces risk of recurrent cardiac events.

• Stroke Prevention

  • Aspirin prevents clot formation, while atorvastatin reduces plaque buildup.

• Stable & Unstable Angina

  • Provides dual protection against ischemic episodes.

• Peripheral Artery Disease (PAD)

  • Improves vascular health and reduces risk of thrombotic events.

• Diabetic Patients with Cardiovascular Risk

  • Offers protection against both lipid abnormalities and platelet aggregation.

ROSEMAE‑10 (Rosuvastatin 10mg Tablet) is a statin therapy used for cholesterol management and cardiovascular risk reduction. It is one of the most potent statins, prescribed for patients with dyslipidemia and high cardiovascular risk.

📌 Key Medical Uses

• Hyperlipidemia / Dyslipidemia

  • Lowers LDL cholesterol and triglycerides, raises HDL cholesterol.

• Primary Prevention of Cardiovascular Disease

  • Reduces risk of heart attack and stroke in patients with risk factors (diabetes, hypertension, family history).

• Secondary Prevention

  • Prevents recurrence of cardiac events in patients with established coronary artery disease.

• Atherosclerosis Management

  • Slows progression of plaque buildup in arteries.

• Adjunct in Diabetes & Metabolic Syndrome

  • Provides cardiovascular protection in patients with multiple metabolic risk factors.

ROSEMAE‑GOLD (Rosuvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule) is a triple‑therapy cardiovascular protection formulation combining a potent statin with dual antiplatelet agents. It is prescribed for patients at very high risk of heart disease and stroke, offering comprehensive protection against cholesterol buildup and clot formation.

📌 Key Medical Uses

• Secondary Prevention of Cardiovascular Events

  • Strong protection against recurrent heart attack, stroke, or angina.

• Post‑Myocardial Infarction (Heart Attack)

  • Statin stabilizes plaques, aspirin + clopidogrel prevent platelet aggregation and clot formation.

• Post‑Stent Placement / Angioplasty

  • Dual antiplatelet therapy (aspirin + clopidogrel) prevents stent thrombosis.

• Coronary Artery Disease (CAD)

  • Slows progression of atherosclerosis and reduces ischemic episodes.

• Peripheral Artery Disease (PAD)

  • Improves vascular health and reduces thrombotic risk.

• High‑Risk Diabetic Patients

  • Provides comprehensive protection against lipid abnormalities and clotting tendencies.

Rosemae F 10 Tablet is a combination of two lipids (fat) lowering medicines. It is used to lower the levels of lipids known as cholesterol and triglycerides in the blood when lifestyle changes (eg. low-fat diet) on their own have failed. This medicine helps to reduce the risk of heart disease.

TICAGOD‑90 (Ticagrelor 90mg Tablet) is a potent oral antiplatelet agent used in cardiology for the prevention of thrombotic cardiovascular events. It belongs to the class of P2Y12 receptor antagonists and is often prescribed alongside aspirin as part of dual antiplatelet therapy (DAPT).

📌 Key Medical Uses

• Acute Coronary Syndrome (ACS)

  • Reduces risk of heart attack, stroke, and cardiovascular death in patients with unstable angina, NSTEMI, or STEMI.

• Post‑Percutaneous Coronary Intervention (PCI / Stent Placement)

  • Prevents stent thrombosis when used with aspirin.

• Secondary Prevention of Cardiovascular Events

  • Long‑term use lowers risk of recurrent myocardial infarction or ischemic stroke.

• Post‑Myocardial Infarction (Heart Attack)

  • Provides stronger platelet inhibition compared to clopidogrel, improving outcomes in high‑risk patients.

Valzeta 50-Tablet is a combination medicine used to treat heart failure. It reduces the risk of hospitalization and death due to long-lasting (chronic) heart failure.

VALZETA‑100 (Valsartan 51mg + Sacubitril 49mg Tablet) is an angiotensin receptor–neprilysin inhibitor (ARNI) combination therapy indicated for the management of heart failure with reduced ejection fraction (HFrEF). It is a modern, guideline‑recommended treatment that improves survival and reduces hospitalizations compared to conventional ACE inhibitors or ARBs.

📌 Key Medical Uses

• Heart Failure with Reduced Ejection Fraction (HFrEF)

  • Improves symptoms such as breathlessness, fatigue, and exercise tolerance.

• Reduction of Cardiovascular Mortality

  • Proven to lower risk of death in patients with chronic heart failure.

• Prevention of Hospitalization

  • Reduces recurrent hospital admissions due to worsening heart failure.

• Adjunct in Hypertension (selected cases)

  • Provides blood pressure control in patients with concomitant heart failure.

VIBEAT‑40 (Telmisartan Hydrochloride 40mg Tablet) is an angiotensin II receptor blocker (ARB) indicated for the management of hypertension and cardiovascular risk reduction. It is widely prescribed due to its long duration of action and metabolic benefits.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Provides 24‑hour blood pressure control with once‑daily dosing.

• Cardiovascular Risk Reduction

  • Lowers risk of heart attack, stroke, and vascular complications in hypertensive patients.

• Diabetic Nephropathy

  • Protects kidneys by reducing proteinuria and slowing progression of diabetic kidney disease.

• Heart Failure (selected cases)

  • Improves cardiac function and reduces hospitalization risk.

• Metabolic Syndrome

  • Telmisartan has partial PPAR‑γ agonist activity, improving insulin sensitivity and lipid profile.

VIBEAT‑AM (Telmisartan 40mg + Amlodipine 5mg Bilayered Tablet) is a fixed‑dose antihypertensive combination that brings together an angiotensin II receptor blocker (ARB) and a calcium channel blocker (CCB). The bilayered formulation ensures optimal release and patient compliance.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Provides dual mechanism: Telmisartan reduces vasoconstriction, Amlodipine relaxes vascular smooth muscle.

• Resistant Hypertension

  • Effective in patients not controlled with monotherapy.

• Cardiovascular Risk Reduction

  • Lowers risk of heart attack, stroke, and vascular complications.

• Diabetic & Metabolic Syndrome Patients

  • Telmisartan offers renal protection and metabolic benefits, while Amlodipine provides potent BP control.

• Long‑term Therapy

  • Once‑daily dosing with sustained release improves adherence and outcomes.

VIBEAT‑AMH (Telmisartan 40mg + Amlodipine 5mg + Hydrochlorothiazide 12.5mg Bilayered Tablet) is a triple‑combination antihypertensive therapy designed for patients with moderate to severe hypertension who require multi‑drug control. The bilayered formulation ensures optimal release and patient compliance.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Provides strong and sustained BP reduction through three complementary mechanisms.

• Resistant Hypertension

  • Effective in patients not controlled with one or two agents.

• Cardiovascular Risk Reduction

  • Lowers risk of stroke, heart attack, and vascular complications.

• Renal Protection in Hypertensive Diabetics

  • Telmisartan reduces proteinuria and protects kidney function.

• Long‑term Therapy

  • Once‑daily dosing improves adherence and outcomes.

VIBEAT‑H (Telmisartan 40mg + Hydrochlorothiazide 12.5mg Bilayered Tablet) is a dual‑combination antihypertensive therapy designed for patients with moderate to severe hypertension who require more than one agent for effective blood pressure control. The bilayered formulation ensures optimal release and patient compliance.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Provides strong and sustained BP reduction through complementary mechanisms.

• Resistant Hypertension

  • Effective in patients not adequately controlled with monotherapy.

• Cardiovascular Risk Reduction

  • Lowers risk of stroke, heart attack, and vascular complications.

• Renal Protection in Hypertensive Diabetics

  • Telmisartan reduces proteinuria and slows progression of kidney disease.

• Long‑term Therapy

  • Once‑daily dosing improves adherence and outcomes.

VIBEAT‑Beta (Telmisartan 40mg + Metoprolol Succinate ER 50mg Bilayered Tablet) is a dual‑combination antihypertensive therapy that merges an angiotensin II receptor blocker (ARB) with a cardio‑selective beta‑blocker. The bilayered extended‑release formulation ensures controlled delivery, improved compliance, and balanced blood pressure plus heart rate control.

📌 Key Medical Uses

• Hypertension (High Blood Pressure)

  • Dual mechanism: Telmisartan reduces vasoconstriction, Metoprolol lowers heart rate and cardiac output.

• Resistant Hypertension

  • Effective in patients not controlled with monotherapy.

• Angina & Post‑Myocardial Infarction

  • Metoprolol reduces myocardial oxygen demand, Telmisartan provides vascular protection.

• Heart Failure (selected cases)

  • Improves cardiac function and reduces hospitalization risk.

• Cardiovascular Risk Reduction

  • Lowers risk of stroke, heart attack, and vascular complications.

ROSEMAE‑GOLD 20 (Rosuvastatin 20mg + Aspirin 75mg + Clopidogrel 75mg Capsule) is a triple‑therapy cardiovascular protection formulation designed for patients at very high risk of heart disease and stroke. It combines a potent statin with dual antiplatelet agents, offering comprehensive protection against cholesterol buildup and clot formation.

📌 Key Medical Uses

• Secondary Prevention of Cardiovascular Events

  • Strong protection against recurrent heart attack, stroke, or angina.

• Post‑Myocardial Infarction (Heart Attack)

  • Rosuvastatin stabilizes plaques, aspirin + clopidogrel prevent platelet aggregation and clot formation.

• Post‑Stent Placement / Angioplasty

  • Dual antiplatelet therapy (aspirin + clopidogrel) prevents stent thrombosis.

• Coronary Artery Disease (CAD)

  • Slows progression of atherosclerosis and reduces ischemic episodes.

• Peripheral Artery Disease (PAD)

  • Improves vascular health and reduces thrombotic risk.

• High‑Risk Diabetic Patients

  • Provides comprehensive protection against lipid abnormalities and clotting tendencies.

ROSEMAE‑A10 (Rosuvastatin 10mg + Aspirin 75mg Capsule) is a dual‑protection cardiovascular therapy combining a potent statin with an antiplatelet agent. It is prescribed for patients at high risk of heart disease and stroke, offering both lipid control and clot prevention in one capsule.

📌 Key Medical Uses

• Secondary Prevention of Cardiovascular Events

  • Reduces risk of recurrent heart attack, stroke, or angina.

• Coronary Artery Disease (CAD)

  • Slows progression of atherosclerosis by lowering cholesterol and preventing clot formation.

• Post‑Myocardial Infarction (Heart Attack)

  • Provides dual protection: statin stabilizes plaques, aspirin prevents platelet aggregation.

• Peripheral Artery Disease (PAD)

  • Improves vascular health and reduces thrombotic risk.

• Diabetic Patients with Cardiovascular Risk

  • Offers comprehensive protection against both lipid abnormalities and clotting tendencies.